Medical Care

Global In-vitro Human Model Market Research Report 2026

This report delivers a comprehensive overview of the global In-vitro Human Model market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding In-vitro Human Model. The In-vitro Human Model market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global In-vitro Human Model market comprehensively. Regional market sizes by Type, by Application, by Primary Cell Source, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist In-vitro Human Model manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Emulate
CN Bio
TissUse
Mimetas
InSphero
Thermo Fisher Scientific
Merck
Corning
Lonza
Danwang Medical
Ketu Medical
Accurate International
Kuraray
N3d Bioscience
Reprocell Incorporated
3D Biotek
Tara Biosystems
Hesperos
Draper Laboratory
Nortis
Segment by Type
Organ-on-chip Systems
3D Tissue Models
Stem-cell Derived Models
Segment by Primary Cell Source
Primary Human Cells
iPSC-derived Human Cells
Tumor Cell Lines
Others
Segment by Organ Scope
Single-organ Model
Multi-organ Connected Model
Other
Segment by Application
Drug Discovery
Toxicity Testing
Disease Modeling
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Primary Cell Source, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for In-vitro Human Model companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In-vitro Human Model Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Organ-on-chip Systems
1.2.3 3D Tissue Models
1.2.4 Stem-cell Derived Models
1.3 Market by Primary Cell Source
1.3.1 Global In-vitro Human Model Market Size Growth Rate by Primary Cell Source: 2021 vs 2025 vs 2032
1.3.2 Primary Human Cells
1.3.3 iPSC-derived Human Cells
1.3.4 Tumor Cell Lines
1.3.5 Others
1.4 Market by Organ Scope
1.4.1 Global In-vitro Human Model Market Size Growth Rate by Organ Scope: 2021 vs 2025 vs 2032
1.4.2 Single-organ Model
1.4.3 Multi-organ Connected Model
1.4.4 Other
1.5 Market by Application
1.5.1 Global In-vitro Human Model Market Growth by Application: 2021 vs 2025 vs 2032
1.5.2 Drug Discovery
1.5.3 Toxicity Testing
1.5.4 Disease Modeling
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global In-vitro Human Model Market Perspective (2021–2032)
2.2 Global In-vitro Human Model Growth Trends by Region
2.2.1 Global In-vitro Human Model Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 In-vitro Human Model Historic Market Size by Region (2021–2026)
2.2.3 In-vitro Human Model Forecasted Market Size by Region (2027–2032)
2.3 In-vitro Human Model Market Dynamics
2.3.1 In-vitro Human Model Industry Trends
2.3.2 In-vitro Human Model Market Drivers
2.3.3 In-vitro Human Model Market Challenges
2.3.4 In-vitro Human Model Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In-vitro Human Model Players by Revenue
3.1.1 Global Top In-vitro Human Model Players by Revenue (2021–2026)
3.1.2 Global In-vitro Human Model Revenue Market Share by Players (2021–2026)
3.2 Global Top In-vitro Human Model Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by In-vitro Human Model Revenue
3.4 Global In-vitro Human Model Market Concentration Ratio
3.4.1 Global In-vitro Human Model Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In-vitro Human Model Revenue in 2025
3.5 Global Key Players of In-vitro Human Model Head Offices and Areas Served
3.6 Global Key Players of In-vitro Human Model, Products and Applications
3.7 Global Key Players of In-vitro Human Model, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 In-vitro Human Model Breakdown Data by Type
4.1 Global In-vitro Human Model Historic Market Size by Type (2021–2026)
4.2 Global In-vitro Human Model Forecasted Market Size by Type (2027–2032)
5 In-vitro Human Model Breakdown Data by Application
5.1 Global In-vitro Human Model Historic Market Size by Application (2021–2026)
5.2 Global In-vitro Human Model Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America In-vitro Human Model Market Size (2021–2032)
6.2 North America In-vitro Human Model Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America In-vitro Human Model Market Size by Country (2021–2026)
6.4 North America In-vitro Human Model Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In-vitro Human Model Market Size (2021–2032)
7.2 Europe In-vitro Human Model Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe In-vitro Human Model Market Size by Country (2021–2026)
7.4 Europe In-vitro Human Model Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific In-vitro Human Model Market Size (2021–2032)
8.2 Asia-Pacific In-vitro Human Model Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific In-vitro Human Model Market Size by Region (2021–2026)
8.4 Asia-Pacific In-vitro Human Model Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America In-vitro Human Model Market Size (2021–2032)
9.2 Latin America In-vitro Human Model Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America In-vitro Human Model Market Size by Country (2021–2026)
9.4 Latin America In-vitro Human Model Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In-vitro Human Model Market Size (2021–2032)
10.2 Middle East & Africa In-vitro Human Model Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa In-vitro Human Model Market Size by Country (2021–2026)
10.4 Middle East & Africa In-vitro Human Model Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Emulate
11.1.1 Emulate Company Details
11.1.2 Emulate Business Overview
11.1.3 Emulate In-vitro Human Model Introduction
11.1.4 Emulate Revenue in In-vitro Human Model Business (2021–2026)
11.1.5 Emulate Recent Development
11.2 CN Bio
11.2.1 CN Bio Company Details
11.2.2 CN Bio Business Overview
11.2.3 CN Bio In-vitro Human Model Introduction
11.2.4 CN Bio Revenue in In-vitro Human Model Business (2021–2026)
11.2.5 CN Bio Recent Development
11.3 TissUse
11.3.1 TissUse Company Details
11.3.2 TissUse Business Overview
11.3.3 TissUse In-vitro Human Model Introduction
11.3.4 TissUse Revenue in In-vitro Human Model Business (2021–2026)
11.3.5 TissUse Recent Development
11.4 Mimetas
11.4.1 Mimetas Company Details
11.4.2 Mimetas Business Overview
11.4.3 Mimetas In-vitro Human Model Introduction
11.4.4 Mimetas Revenue in In-vitro Human Model Business (2021–2026)
11.4.5 Mimetas Recent Development
11.5 InSphero
11.5.1 InSphero Company Details
11.5.2 InSphero Business Overview
11.5.3 InSphero In-vitro Human Model Introduction
11.5.4 InSphero Revenue in In-vitro Human Model Business (2021–2026)
11.5.5 InSphero Recent Development
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Details
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific In-vitro Human Model Introduction
11.6.4 Thermo Fisher Scientific Revenue in In-vitro Human Model Business (2021–2026)
11.6.5 Thermo Fisher Scientific Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck In-vitro Human Model Introduction
11.7.4 Merck Revenue in In-vitro Human Model Business (2021–2026)
11.7.5 Merck Recent Development
11.8 Corning
11.8.1 Corning Company Details
11.8.2 Corning Business Overview
11.8.3 Corning In-vitro Human Model Introduction
11.8.4 Corning Revenue in In-vitro Human Model Business (2021–2026)
11.8.5 Corning Recent Development
11.9 Lonza
11.9.1 Lonza Company Details
11.9.2 Lonza Business Overview
11.9.3 Lonza In-vitro Human Model Introduction
11.9.4 Lonza Revenue in In-vitro Human Model Business (2021–2026)
11.9.5 Lonza Recent Development
11.10 Danwang Medical
11.10.1 Danwang Medical Company Details
11.10.2 Danwang Medical Business Overview
11.10.3 Danwang Medical In-vitro Human Model Introduction
11.10.4 Danwang Medical Revenue in In-vitro Human Model Business (2021–2026)
11.10.5 Danwang Medical Recent Development
11.11 Ketu Medical
11.11.1 Ketu Medical Company Details
11.11.2 Ketu Medical Business Overview
11.11.3 Ketu Medical In-vitro Human Model Introduction
11.11.4 Ketu Medical Revenue in In-vitro Human Model Business (2021–2026)
11.11.5 Ketu Medical Recent Development
11.12 Accurate International
11.12.1 Accurate International Company Details
11.12.2 Accurate International Business Overview
11.12.3 Accurate International In-vitro Human Model Introduction
11.12.4 Accurate International Revenue in In-vitro Human Model Business (2021–2026)
11.12.5 Accurate International Recent Development
11.13 Kuraray
11.13.1 Kuraray Company Details
11.13.2 Kuraray Business Overview
11.13.3 Kuraray In-vitro Human Model Introduction
11.13.4 Kuraray Revenue in In-vitro Human Model Business (2021–2026)
11.13.5 Kuraray Recent Development
11.14 N3d Bioscience
11.14.1 N3d Bioscience Company Details
11.14.2 N3d Bioscience Business Overview
11.14.3 N3d Bioscience In-vitro Human Model Introduction
11.14.4 N3d Bioscience Revenue in In-vitro Human Model Business (2021–2026)
11.14.5 N3d Bioscience Recent Development
11.15 Reprocell Incorporated
11.15.1 Reprocell Incorporated Company Details
11.15.2 Reprocell Incorporated Business Overview
11.15.3 Reprocell Incorporated In-vitro Human Model Introduction
11.15.4 Reprocell Incorporated Revenue in In-vitro Human Model Business (2021–2026)
11.15.5 Reprocell Incorporated Recent Development
11.16 3D Biotek
11.16.1 3D Biotek Company Details
11.16.2 3D Biotek Business Overview
11.16.3 3D Biotek In-vitro Human Model Introduction
11.16.4 3D Biotek Revenue in In-vitro Human Model Business (2021–2026)
11.16.5 3D Biotek Recent Development
11.17 Tara Biosystems
11.17.1 Tara Biosystems Company Details
11.17.2 Tara Biosystems Business Overview
11.17.3 Tara Biosystems In-vitro Human Model Introduction
11.17.4 Tara Biosystems Revenue in In-vitro Human Model Business (2021–2026)
11.17.5 Tara Biosystems Recent Development
11.18 Hesperos
11.18.1 Hesperos Company Details
11.18.2 Hesperos Business Overview
11.18.3 Hesperos In-vitro Human Model Introduction
11.18.4 Hesperos Revenue in In-vitro Human Model Business (2021–2026)
11.18.5 Hesperos Recent Development
11.19 Draper Laboratory
11.19.1 Draper Laboratory Company Details
11.19.2 Draper Laboratory Business Overview
11.19.3 Draper Laboratory In-vitro Human Model Introduction
11.19.4 Draper Laboratory Revenue in In-vitro Human Model Business (2021–2026)
11.19.5 Draper Laboratory Recent Development
11.20 Nortis
11.20.1 Nortis Company Details
11.20.2 Nortis Business Overview
11.20.3 Nortis In-vitro Human Model Introduction
11.20.4 Nortis Revenue in In-vitro Human Model Business (2021–2026)
11.20.5 Nortis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global In-vitro Human Model Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Organ-on-chip Systems
Table 3. Key Players of 3D Tissue Models
Table 4. Key Players of Stem-cell Derived Models
Table 5. Global In-vitro Human Model Market Size Growth Rate by Primary Cell Source (US$ Million): 2021 vs 2025 vs 2032
Table 6. Key Players of Primary Human Cells
Table 7. Key Players of iPSC-derived Human Cells
Table 8. Key Players of Tumor Cell Lines
Table 9. Key Players of Others
Table 10. Global In-vitro Human Model Market Size Growth Rate by Organ Scope (US$ Million): 2021 vs 2025 vs 2032
Table 11. Key Players of Single-organ Model
Table 12. Key Players of Multi-organ Connected Model
Table 13. Key Players of Other
Table 14. Global In-vitro Human Model Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 15. Global In-vitro Human Model Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 16. Global In-vitro Human Model Market Size by Region (US$ Million), 2021–2026
Table 17. Global In-vitro Human Model Market Share by Region (2021–2026)
Table 18. Global In-vitro Human Model Forecasted Market Size by Region (US$ Million), 2027–2032
Table 19. Global In-vitro Human Model Market Share by Region (2027–2032)
Table 20. In-vitro Human Model Market Trends
Table 21. In-vitro Human Model Market Drivers
Table 22. In-vitro Human Model Market Challenges
Table 23. In-vitro Human Model Market Restraints
Table 24. Global In-vitro Human Model Revenue by Players (US$ Million), 2021–2026
Table 25. Global In-vitro Human Model Market Share by Players (2021–2026)
Table 26. Global Top In-vitro Human Model Players by Tier (Tier 1, Tier 2, and Tier 3), based on In-vitro Human Model Revenue, 2025
Table 27. Ranking of Global Top In-vitro Human Model Companies by Revenue (US$ Million) in 2025
Table 28. Global 5 Largest Players Market Share by In-vitro Human Model Revenue (CR5 and HHI), 2021–2026
Table 29. Global Key Players of In-vitro Human Model, Headquarters and Area Served
Table 30. Global Key Players of In-vitro Human Model, Products and Applications
Table 31. Global Key Players of In-vitro Human Model, Date of General Availability (GA)
Table 32. Mergers and Acquisitions, Expansion Plans
Table 33. Global In-vitro Human Model Market Size by Type (US$ Million), 2021–2026
Table 34. Global In-vitro Human Model Revenue Market Share by Type (2021–2026)
Table 35. Global In-vitro Human Model Forecasted Market Size by Type (US$ Million), 2027–2032
Table 36. Global In-vitro Human Model Revenue Market Share by Type (2027–2032)
Table 37. Global In-vitro Human Model Market Size by Application (US$ Million), 2021–2026
Table 38. Global In-vitro Human Model Revenue Market Share by Application (2021–2026)
Table 39. Global In-vitro Human Model Forecasted Market Size by Application (US$ Million), 2027–2032
Table 40. Global In-vitro Human Model Revenue Market Share by Application (2027–2032)
Table 41. North America In-vitro Human Model Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. North America In-vitro Human Model Market Size by Country (US$ Million), 2021–2026
Table 43. North America In-vitro Human Model Market Size by Country (US$ Million), 2027–2032
Table 44. Europe In-vitro Human Model Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Europe In-vitro Human Model Market Size by Country (US$ Million), 2021–2026
Table 46. Europe In-vitro Human Model Market Size by Country (US$ Million), 2027–2032
Table 47. Asia-Pacific In-vitro Human Model Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 48. Asia-Pacific In-vitro Human Model Market Size by Region (US$ Million), 2021–2026
Table 49. Asia-Pacific In-vitro Human Model Market Size by Region (US$ Million), 2027–2032
Table 50. Latin America In-vitro Human Model Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 51. Latin America In-vitro Human Model Market Size by Country (US$ Million), 2021–2026
Table 52. Latin America In-vitro Human Model Market Size by Country (US$ Million), 2027–2032
Table 53. Middle East & Africa In-vitro Human Model Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 54. Middle East & Africa In-vitro Human Model Market Size by Country (US$ Million), 2021–2026
Table 55. Middle East & Africa In-vitro Human Model Market Size by Country (US$ Million), 2027–2032
Table 56. Emulate Company Details
Table 57. Emulate Business Overview
Table 58. Emulate In-vitro Human Model Product
Table 59. Emulate Revenue in In-vitro Human Model Business (US$ Million), 2021–2026
Table 60. Emulate Recent Development
Table 61. CN Bio Company Details
Table 62. CN Bio Business Overview
Table 63. CN Bio In-vitro Human Model Product
Table 64. CN Bio Revenue in In-vitro Human Model Business (US$ Million), 2021–2026
Table 65. CN Bio Recent Development
Table 66. TissUse Company Details
Table 67. TissUse Business Overview
Table 68. TissUse In-vitro Human Model Product
Table 69. TissUse Revenue in In-vitro Human Model Business (US$ Million), 2021–2026
Table 70. TissUse Recent Development
Table 71. Mimetas Company Details
Table 72. Mimetas Business Overview
Table 73. Mimetas In-vitro Human Model Product
Table 74. Mimetas Revenue in In-vitro Human Model Business (US$ Million), 2021–2026
Table 75. Mimetas Recent Development
Table 76. InSphero Company Details
Table 77. InSphero Business Overview
Table 78. InSphero In-vitro Human Model Product
Table 79. InSphero Revenue in In-vitro Human Model Business (US$ Million), 2021–2026
Table 80. InSphero Recent Development
Table 81. Thermo Fisher Scientific Company Details
Table 82. Thermo Fisher Scientific Business Overview
Table 83. Thermo Fisher Scientific In-vitro Human Model Product
Table 84. Thermo Fisher Scientific Revenue in In-vitro Human Model Business (US$ Million), 2021–2026
Table 85. Thermo Fisher Scientific Recent Development
Table 86. Merck Company Details
Table 87. Merck Business Overview
Table 88. Merck In-vitro Human Model Product
Table 89. Merck Revenue in In-vitro Human Model Business (US$ Million), 2021–2026
Table 90. Merck Recent Development
Table 91. Corning Company Details
Table 92. Corning Business Overview
Table 93. Corning In-vitro Human Model Product
Table 94. Corning Revenue in In-vitro Human Model Business (US$ Million), 2021–2026
Table 95. Corning Recent Development
Table 96. Lonza Company Details
Table 97. Lonza Business Overview
Table 98. Lonza In-vitro Human Model Product
Table 99. Lonza Revenue in In-vitro Human Model Business (US$ Million), 2021–2026
Table 100. Lonza Recent Development
Table 101. Danwang Medical Company Details
Table 102. Danwang Medical Business Overview
Table 103. Danwang Medical In-vitro Human Model Product
Table 104. Danwang Medical Revenue in In-vitro Human Model Business (US$ Million), 2021–2026
Table 105. Danwang Medical Recent Development
Table 106. Ketu Medical Company Details
Table 107. Ketu Medical Business Overview
Table 108. Ketu Medical In-vitro Human Model Product
Table 109. Ketu Medical Revenue in In-vitro Human Model Business (US$ Million), 2021–2026
Table 110. Ketu Medical Recent Development
Table 111. Accurate International Company Details
Table 112. Accurate International Business Overview
Table 113. Accurate International In-vitro Human Model Product
Table 114. Accurate International Revenue in In-vitro Human Model Business (US$ Million), 2021–2026
Table 115. Accurate International Recent Development
Table 116. Kuraray Company Details
Table 117. Kuraray Business Overview
Table 118. Kuraray In-vitro Human Model Product
Table 119. Kuraray Revenue in In-vitro Human Model Business (US$ Million), 2021–2026
Table 120. Kuraray Recent Development
Table 121. N3d Bioscience Company Details
Table 122. N3d Bioscience Business Overview
Table 123. N3d Bioscience In-vitro Human Model Product
Table 124. N3d Bioscience Revenue in In-vitro Human Model Business (US$ Million), 2021–2026
Table 125. N3d Bioscience Recent Development
Table 126. Reprocell Incorporated Company Details
Table 127. Reprocell Incorporated Business Overview
Table 128. Reprocell Incorporated In-vitro Human Model Product
Table 129. Reprocell Incorporated Revenue in In-vitro Human Model Business (US$ Million), 2021–2026
Table 130. Reprocell Incorporated Recent Development
Table 131. 3D Biotek Company Details
Table 132. 3D Biotek Business Overview
Table 133. 3D Biotek In-vitro Human Model Product
Table 134. 3D Biotek Revenue in In-vitro Human Model Business (US$ Million), 2021–2026
Table 135. 3D Biotek Recent Development
Table 136. Tara Biosystems Company Details
Table 137. Tara Biosystems Business Overview
Table 138. Tara Biosystems In-vitro Human Model Product
Table 139. Tara Biosystems Revenue in In-vitro Human Model Business (US$ Million), 2021–2026
Table 140. Tara Biosystems Recent Development
Table 141. Hesperos Company Details
Table 142. Hesperos Business Overview
Table 143. Hesperos In-vitro Human Model Product
Table 144. Hesperos Revenue in In-vitro Human Model Business (US$ Million), 2021–2026
Table 145. Hesperos Recent Development
Table 146. Draper Laboratory Company Details
Table 147. Draper Laboratory Business Overview
Table 148. Draper Laboratory In-vitro Human Model Product
Table 149. Draper Laboratory Revenue in In-vitro Human Model Business (US$ Million), 2021–2026
Table 150. Draper Laboratory Recent Development
Table 151. Nortis Company Details
Table 152. Nortis Business Overview
Table 153. Nortis In-vitro Human Model Product
Table 154. Nortis Revenue in In-vitro Human Model Business (US$ Million), 2021–2026
Table 155. Nortis Recent Development
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
Table 159. Authors List of This Report


List of Figures
Figure 1. In-vitro Human Model Picture
Figure 2. Global In-vitro Human Model Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global In-vitro Human Model Market Share by Type: 2025 vs 2032
Figure 4. Organ-on-chip Systems Features
Figure 5. 3D Tissue Models Features
Figure 6. Stem-cell Derived Models Features
Figure 7. Global In-vitro Human Model Market Size Comparison by Primary Cell Source (US$ Million), 2021–2032
Figure 8. Primary Human Cells Features
Figure 9. iPSC-derived Human Cells Features
Figure 10. Tumor Cell Lines Features
Figure 11. Others Features
Figure 12. Global In-vitro Human Model Market Size Comparison by Organ Scope (US$ Million), 2021–2032
Figure 13. Single-organ Model Features
Figure 14. Multi-organ Connected Model Features
Figure 15. Other Features
Figure 16. Global In-vitro Human Model Market Size by Application (US$ Million), 2021–2032
Figure 17. Global In-vitro Human Model Market Share by Application: 2025 vs 2032
Figure 18. Drug Discovery Case Studies
Figure 19. Toxicity Testing Case Studies
Figure 20. Disease Modeling Case Studies
Figure 21. In-vitro Human Model Report Years Considered
Figure 22. Global In-vitro Human Model Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 23. Global In-vitro Human Model Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 24. Global In-vitro Human Model Market Share by Region: 2025 vs 2032
Figure 25. Global In-vitro Human Model Market Share by Players in 2025
Figure 26. Global In-vitro Human Model Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 27. The Top 10 and 5 Players Market Share by In-vitro Human Model Revenue in 2025
Figure 28. North America In-vitro Human Model Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. North America In-vitro Human Model Market Share by Country (2021–2032)
Figure 30. United States In-vitro Human Model Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Canada In-vitro Human Model Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Europe In-vitro Human Model Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Europe In-vitro Human Model Market Share by Country (2021–2032)
Figure 34. Germany In-vitro Human Model Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. France In-vitro Human Model Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. U.K. In-vitro Human Model Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Italy In-vitro Human Model Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Russia In-vitro Human Model Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Ireland In-vitro Human Model Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Asia-Pacific In-vitro Human Model Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Asia-Pacific In-vitro Human Model Market Share by Region (2021–2032)
Figure 42. China In-vitro Human Model Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Japan In-vitro Human Model Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. South Korea In-vitro Human Model Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Southeast Asia In-vitro Human Model Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. India In-vitro Human Model Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Australia & New Zealand In-vitro Human Model Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Latin America In-vitro Human Model Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Latin America In-vitro Human Model Market Share by Country (2021–2032)
Figure 50. Mexico In-vitro Human Model Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. Brazil In-vitro Human Model Market Size YoY Growth (US$ Million), 2021–2032
Figure 52. Middle East & Africa In-vitro Human Model Market Size YoY Growth (US$ Million), 2021–2032
Figure 53. Middle East & Africa In-vitro Human Model Market Share by Country (2021–2032)
Figure 54. Israel In-vitro Human Model Market Size YoY Growth (US$ Million), 2021–2032
Figure 55. Saudi Arabia In-vitro Human Model Market Size YoY Growth (US$ Million), 2021–2032
Figure 56. UAE In-vitro Human Model Market Size YoY Growth (US$ Million), 2021–2032
Figure 57. Emulate Revenue Growth Rate in In-vitro Human Model Business (2021–2026)
Figure 58. CN Bio Revenue Growth Rate in In-vitro Human Model Business (2021–2026)
Figure 59. TissUse Revenue Growth Rate in In-vitro Human Model Business (2021–2026)
Figure 60. Mimetas Revenue Growth Rate in In-vitro Human Model Business (2021–2026)
Figure 61. InSphero Revenue Growth Rate in In-vitro Human Model Business (2021–2026)
Figure 62. Thermo Fisher Scientific Revenue Growth Rate in In-vitro Human Model Business (2021–2026)
Figure 63. Merck Revenue Growth Rate in In-vitro Human Model Business (2021–2026)
Figure 64. Corning Revenue Growth Rate in In-vitro Human Model Business (2021–2026)
Figure 65. Lonza Revenue Growth Rate in In-vitro Human Model Business (2021–2026)
Figure 66. Danwang Medical Revenue Growth Rate in In-vitro Human Model Business (2021–2026)
Figure 67. Ketu Medical Revenue Growth Rate in In-vitro Human Model Business (2021–2026)
Figure 68. Accurate International Revenue Growth Rate in In-vitro Human Model Business (2021–2026)
Figure 69. Kuraray Revenue Growth Rate in In-vitro Human Model Business (2021–2026)
Figure 70. N3d Bioscience Revenue Growth Rate in In-vitro Human Model Business (2021–2026)
Figure 71. Reprocell Incorporated Revenue Growth Rate in In-vitro Human Model Business (2021–2026)
Figure 72. 3D Biotek Revenue Growth Rate in In-vitro Human Model Business (2021–2026)
Figure 73. Tara Biosystems Revenue Growth Rate in In-vitro Human Model Business (2021–2026)
Figure 74. Hesperos Revenue Growth Rate in In-vitro Human Model Business (2021–2026)
Figure 75. Draper Laboratory Revenue Growth Rate in In-vitro Human Model Business (2021–2026)
Figure 76. Nortis Revenue Growth Rate in In-vitro Human Model Business (2021–2026)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies